Research Feeds

View All
Characterizing the gut microbiota in females with infertility and preliminary results of a water-soluble dietary fiber intervention study A prebiotic dietary pilot intervention restores faecal metabolites and may be neuroprotective in Parkinson’s Disease Diagnosis of the menopause: NICE guidance and quality standards Causes of Death in End-Stage Kidney Disease: Comparison Between the United States Renal Data System and a Large Integrated Health Care System Fecal calprotectin biomarker in IBD: Clinical Use Increased intestinal absorption of foreign organic compounds in the presence of ethylenediaminetetraacetic acid (EDTA) Cytochrome c-549-an endogenous cofactor of cyclic photophosphorylation in the cyanobacterium Anacystis nidulans? Factors affecting the absorption and excretion of lead in the rat Factors associated with age at menarche, menstrual knowledge, and hygiene practices among schoolgirls in Sharjah, UAE Cadmium transport in blood serum The non-pathogenic Escherichia coli strain Nissle 1917 – features of a versatile probiotic Structured Exercise Benefits in Euthyroid Graves’ Disease: Improved Capacity, Fatigue, and Relapse Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease A Pilot Microbiota Study in Parkinson’s Disease Patients versus Control Subjects, and Effects of FTY720 and FTY720-Mitoxy Therapies in Parkinsonian and Multiple System Atrophy Mouse Models Dysbiosis of the Saliva Microbiome in Patients With Polycystic Ovary Syndrome

Zinc and manganese chelation by neutrophil S100A8/A9 (calprotectin) limits extracellular Aspergillus fumigatus hyphal growth and corneal infection Original paper

Researched by:

  • Dr. Umar ID
    Dr. Umar

    User avatarClinical Pharmacist and Clinical Pharmacy Master’s candidate focused on antibiotic stewardship, AI-driven pharmacy practice, and research that strengthens safe and effective medication use. Experience spans digital health research with Bloomsbury Health (London), pharmacovigilance in patient support programs, and behavioral approaches to mental health care. Published work includes studies on antibiotic use and awareness, AI applications in medicine, postpartum depression management, and patient safety reporting. Developer of an AI-based clinical decision support system designed to enhance antimicrobial stewardship and optimize therapeutic outcomes.

    Read More

January 1, 2026

Researched by:

  • Dr. Umar ID
    Dr. Umar

    User avatarClinical Pharmacist and Clinical Pharmacy Master’s candidate focused on antibiotic stewardship, AI-driven pharmacy practice, and research that strengthens safe and effective medication use. Experience spans digital health research with Bloomsbury Health (London), pharmacovigilance in patient support programs, and behavioral approaches to mental health care. Published work includes studies on antibiotic use and awareness, AI applications in medicine, postpartum depression management, and patient safety reporting. Developer of an AI-based clinical decision support system designed to enhance antimicrobial stewardship and optimize therapeutic outcomes.

    Read More

Last Updated: 2026-01-01

Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.

Dr. Umar

Clinical Pharmacist and Clinical Pharmacy Master’s candidate focused on antibiotic stewardship, AI-driven pharmacy practice, and research that strengthens safe and effective medication use. Experience spans digital health research with Bloomsbury Health (London), pharmacovigilance in patient support programs, and behavioral approaches to mental health care. Published work includes studies on antibiotic use and awareness, AI applications in medicine, postpartum depression management, and patient safety reporting. Developer of an AI-based clinical decision support system designed to enhance antimicrobial stewardship and optimize therapeutic outcomes.

What was studied?

This original research article tested whether calprotectin limits Aspergillus hyphal growth during infection, and which metal-binding functions explain that activity. Using a murine corneal infection (fungal keratitis) model plus in vitro hyphal growth assays, the authors examined neutrophil-derived calprotectin (the S100A8/S100A9 heterodimer) as a mechanism of “nutritional immunity,” specifically zinc (Zn) and manganese (Mn) sequestration. They also used engineered calprotectin mutants that selectively lose Zn/Mn binding, and Aspergillus fumigatus strains with impaired Zn uptake (ΔzafA) to test whether fungal metal-acquisition pathways determine susceptibility to host chelation.

Who was studied?

The work was preclinical and mechanistic. In vivo experiments used C57BL/6 wild-type mice and calprotectin-deficient S100A9 knockout mice (S100A9⁻/⁻), infected intrastromally with dsRed-expressing A. fumigatus conidia to quantify fungal burden and hyphal mass in corneas at 24–48 hours post-infection. Additional mouse models included CD18-deficient mice (impaired neutrophil transmigration) and bone marrow chimeras to assess pulmonary challenge outcomes. In vitro assays used purified mouse peritoneal neutrophils and neutrophil lysates, as well as neutrophils from healthy adult human donors (18–65 years) to confirm conserved antifungal effects and metal-dependence.

Most important findings

Calprotectin was essential for controlling extracellular hyphal growth in the cornea but was dispensable for intracellular conidial uptake and killing. S100A9⁻/⁻ mice developed significantly higher fungal burden and CFU in infected corneas despite similar neutrophil recruitment, implying a qualitative defect in antifungal function rather than impaired inflammation. Recombinant calprotectin delivered locally restored protection, directly reducing hyphal mass in S100A9⁻/⁻ corneas. Mechanistically, antihyphal activity required metal chelation: wild-type calprotectin strongly inhibited hyphae; a mutant lacking both Zn and Mn binding (CPΔZn/Mn) lost antifungal activity, while a Mn-binding–defective mutant (CPΔMn) showed only partial loss—supporting Zn chelation as primary with Mn as contributory. Hyphal growth could be rescued by adding Zn (fully) and only partially by Mn alone, and human neutrophil inhibition was reversed by Zn but not Mn. Finally, the fungal ΔzafA mutant (defective Zn transport regulation) was hypersusceptible to calprotectin/neutrophils and showed reduced virulence in the cornea, linking a specific microbial nutrient-acquisition program to a host-derived metal-sequestration pressure.

Microbiome signature elementDirection/association
Aspergillus fumigatus hyphal growthInhibited by host calprotectin via Zn+Mn chelation
Calprotectin (S100A8/S100A9)Protective determinant in corneal keratitis; neutrophil-derived
Zn transport regulator ZafA (fungal)Loss increases susceptibility and lowers corneal virulence
Conidial killing (intracellular)Not dependent on calprotectin in lung or in vitro assays

Key implications

Clinically, this study highlights a stage-specific antifungal defense: calprotectin-driven Zn/Mn sequestration targets extracellular hyphae—precisely the invasive, tissue-damaging form relevant to fungal keratitis—while not materially influencing early conidial handling in an immunocompetent lung model. For a microbiome/signatures database, the key actionable association is a host factor (calprotectin) that suppresses A. fumigatus growth by depriving essential metals, plus a microbial counterstrategy (ZafA-regulated Zn uptake) that predicts resistance and virulence. These findings support therapeutic concepts that augment local metal sequestration (e.g., topical calprotectin-like strategies) or inhibit fungal Zn acquisition pathways as adjuncts to antifungal drugs, especially in settings where hyphae dominate (corneal infection, neutropenia, or impaired neutrophil function).

Citation

Clark HL, Jhingran A, Sun Y, et al. Zinc and manganese chelation by neutrophil S100A8/A9 (calprotectin) limits extracellular Aspergillus fumigatus hyphal growth and corneal infection.J Immunol. 2016;196:000-000. Published online November 18, 2015. doi:10.4049/jimmunol.1502037

Calprotectin

Calprotectin is a neutrophil-derived protein complex measured in stool to detect intestinal inflammation. It helps distinguish IBD from functional bowel disorders and reflects mucosal immune activity that can reshape microbiome composition through antimicrobial metal sequestration.

Chelation

Chelation is a biochemical and pharmacological process in which small-molecule chelating agents bind to metal ions with high affinity to sequester, redistribute, or remove metallic elements from biological systems.

Join the Roundtable

Contribute to published consensus reports, connect with top clinicians and researchers, and receive exclusive invitations to roundtable conferences.